Qsymia Development
Vanton designs Qsymia (called Qnexa in its early stage) formulation. It consists of an IR component and a SR component.
Vanton’s contribution include:
- Characterizing API including API packaging and stability
- Formulation design/consultation
- Dosage form design and process (working with CMO)
- Drug product stability and degradation mechanism modeling
- Participate in NDA CMC section
- Post-market support and product return
- Design a second generation Qsymia (bilayer tablet)
